◼ Archived
Business
🔮 fades
Merck gets US FDA nod for first-in-its-class oral cholesterol drug
Merck has achieved a regulatory milestone with the FDA approval of Lipfendra, the first-of-its-kind oral treatment for reducing cholesterol.